Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
bioSeedin Expanded Global Licensing and Partnership Opportunities at 2024 BIO International Convention 2024-06-26 21:00
Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau 2024-06-26 20:56
Fufang E'jiao Syrup's Breakthrough Research on Cancer-Related Fatigue Receives "Special Excellence Award" at 2024 ASCO Annual Meeting 2024-06-26 18:42
Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA 2024-06-26 12:36
Hyundai Bioscience succeeds in developing 'Multi-treatment for mosquito-borne viral infections' including Dengue Fever 2024-06-26 09:17
ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation 2024-06-25 21:00
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services 2024-06-25 20:00
NX Group Signs Strategic Partnership Agreement with Controlant of Iceland 2024-06-25 14:00
TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024 2024-06-24 20:00
Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM 2024-06-20 14:51
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group 2024-06-20 08:44
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma 2024-06-19 19:30
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a Phase I/II Clinical Trial Treating Advanced Solid Tumor Patients with KRAS G12D Mutation 2024-06-19 19:00
Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health 2024-06-19 18:10
Tang Prize in Biopharmaceutical Science Honoring Three Scientists 2024-06-19 12:15
YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China 2024-06-19 09:00
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals 2024-06-17 22:00
Leads Biolabs Unveils Preclinical Data on LBL-047, a Novel, First-In-Class Long-Acting TACI/Anti-BDCA2 Bispecific Antibody Fusion Protein in an Oral Presentation at EULAR 2024 Congress 2024-06-17 18:00
IASO Bio Presented New Data of FUCASO® (Equecabtagene Autoleucel) for the Treatment of High-risk Newly Diagnosed Multiple Myeloma in Oral Presentation at EHA 2024 2024-06-15 22:30
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024 2024-06-15 20:50
1 6 7 8 9 10 159